|
Market Closed -
Euronext Paris
16:55:00 19/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.200 EUR | +2.33% |
|
-0.90% | -18.82% |
| 10-01 | Taconic Biosciences, Inc. And genOway Partner To Expand U.S. Access To Advanced Humanized Mouse Models | CI |
| 09-23 | GenOway teams up with Taconic Biosciences to accelerate in the United States |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 22.3M | - | - | - | - | - |
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- ALGEN Stock
- Charts genOway
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
